Name: VIR Balance Sheet - Vir Biotechnology Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

VIR - Vir Biotechnology, Inc.

USD | NASDAQ | Healthcare

VIR Balance Sheet - Vir Biotechnology Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash And Short Term Investments
Cash And Equivalents	232.2	222.9	241.6	848.6	347.8	436.6	109.3	47.6	187.9	-
Restricted Cash	1.9	95.7	13.3	12.7	8.6	8.0	6.2	10.8	-	-
Short Term Investments	228.8	678.1	1,271.0	1,521.5	217.2	300.3	274.1	50.8	-	-
Cash And Short Term Investments	460.9	901.0	1,512.6	2,370.1	565.0	736.9	383.4	98.4	187.9	-
Receivables
Accounts Receivable	-	-	-	0.0	773.1	0.0	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	45.1	47.7	52.5	104.4
Non-Current Assets
Property, Plant & Equipment Gross	102.8	100.0	129.9	126.4	57.3	27.2	21.1	14.0	-	-
Accumulated Depreciation	47.2	36.8
Current Liabilities
Accounts Payable	9.8	5.1	6.3	6.4	6.5	5.1	5.9	6.5	-	-
Short Term Debt	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	89.1	90.1	111.7
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-
Additional Paid In Capital	1,965.1	1,911.9	1,828.9	1,709.8
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q4 FY 17	Q4 FY 16
Cash And Short Term Investments
Cash And Equivalents	274.2	232.2	170.1	211.1	273.6	222.9	168.4	296.9	160.7	241.6	452.1	666.9	824.9	848.6	963.7

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	44.8	45.1	37.0	41.5	42.4	47.7	43.1	40.7	50.0	52.5	59.4	85.7	97.6	104.4	54.2	72.4	69.9	73.0
Other Current Assets	-	-	-	-	-	-	0.0	1.0	4.1	7.6	4.8	13.0	17.9	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	523.0	514.1	545.7	735.7	932.2	1,042.5	1,047.2	1,205.7	1,213.1	1,588.2	1,769.2	1,946.3	2,358.6	2,519.1	2,413.6	2,288.3

Non-Current Assets
Property, Plant & Equipment Gross	103.1	102.8	102.7	102.4	100.6	100.0	100.0	99.0	130.6	129.9	129.0	130.0	130.0	126.4	119.2	102.5	81.5	57.3	39.7	32.0	27.8	27.2	25.0	23.2	22.1	21.1	19.6	-	-	14.0	-	-	-	-
Accumulated Depreciation	49.9	47.2	44.5	41.6	38.9	36.8	35.2	33.0	38.1	33.9	29.6	25.9	26.2	20.7	18.9	17.4	15.9
Property,Plant & Equipment Net	53.2	55.6	58.2	60.8	61.7	63.2	64.8	66.1	92.5	96.0	99.3	104.1	103.8	105.6	100.2	85.1
Long Term Investments	333.0	314.6	304.2	286.1	218.1	190.0	271.5	280.0	359.7	105.3	39.6	52.4	49.2	23.9	34.1	97.6	103.5
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	16.9	16.9	16.9	16.9	16.9	16.9	16.9	16.9	16.9	16.9	16.9	16.9	16.9	16.9	16.9	16.9	16.9	16.9
Intangible Assets	7.8	7.9	7.9	8.0	8.1	8.1	19.3	18.9	22.5	22.6	25.5	25.6	32.6	32.8	32.9	33.0	33.2
Operating Lease Right Of Use Assets	60.8	62.1	63.6	64.9	58.6	59.7	60.8	62.3	70.3	71.2	72.6	74.9	81.5	82.6	84.7	86.9
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	1,025.6	1,002.8	1,019.5	1,192.5	1,307.7	1,398.8	1,498.4	1,669.6	1,794.0	1,919.1	2,044.9	2,243.9	2,665.9	2,802.1	2,696.0	2,619.0

Current Liabilities
Accounts Payable	5.4	9.8	6.8	12.2	3.7	5.1	7.3	4.4	7.1	6.3	3.6	12.4	12.1	6.4	2.7	10.6	11.0	6.5	4.2	11.0	3.7	5.1	6.8	4.4	18.8	5.9	5.8	-	-	6.5	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	0.0	10.1	11.9	12.6	15.2	16.7	14.7	64.9	15.3	15.7	17.2	15.5	22.9	113.2	113.7
Operating Lease Liabilities Current	8.9	8.8	9.0	8.8	7.9	7.8	19.4	19.5	11.9	12.9	13.6	13.5	7.3	4.1	4.1	4.1
Accrued Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	73.6	92.8	75.2	105.0	137.3	119.7	117.2	96.4	94.1	175.4	165.1	225.6	485.3	511.0	308.2

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	86.6	89.1	91.2	93.4	88.2	90.1	93.4	95.0	109.2	111.7	114.1	117.8	121.5	123.8	126.9
Deferred Revenue Non-Current	-	-	9.4	-	-	0.0	-	-	1.5	1.5	53.2	53.2	53.2	53.2	54.7	4.4	5.9
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	3.3	3.3	18.4	18.4	18.4
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	19.4	21.6	13.3	13.0	14.8	14.6	13.9	13.9	14.2	15.8	13.1	12.1	8.2	11.1	7.2	7.6
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	212.8	237.5	223.4	245.1	263.9	248.4	257.6	235.9	246.6	328.8	369.8	433.7	695.1	724.1	546.1	667.0

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	0.0	-	-	-	-
Additional Paid In Capital	2,139.7	1,965.1	1,952.8	1,941.4	1,926.5	1,911.9	1,894.8	1,878.0	1,852.8	1,828.9	1,798.8	1,771.5	1,737.6	1,709.8	1,682.9	1,656.0
Retained Earnings	(1,323.5)	(1,197.8)	(1,154.8)	(991.7)	(880.7)	(759.8)	(655.2)	(441.5)	(303.1)	(237.8)	(121.9)	41.6	236.3	377.2	478.8	303.5	380.0
Accumulated Other Comprehensive Income	(3.5)	(2.1)	(1.9)	(2.2)	(2.0)	(1.7)	1.1	(2.9)	(2.4)	(0.8)	(1.9)	(2.9)	(3.2)	(9.1)	(11.9)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	0.0	0.0	-	-	-	-
Total Stockholders Equity	812.8	765.3	796.1	947.5	1,043.8	1,150.4	1,240.7	1,433.7	1,547.4	1,590.2	1,675.1	1,810.2	1,970.8	2,078.0	2,149.9	1,952.0
Total Equity	812.8	765.3	796.1	947.5	1,043.8	1,150.4	1,240.7	1,433.7	1,547.4	1,590.2	1,675.1	1,810.2	1,970.8	2,078.0	2,149.9	1,952.0	2,001.0	1,431.8

Receivables
Accounts Receivable	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	7.0	1,223.2	773.1	93.0	-	112.5	0.0	-	-	-	-	-	-	-	-	-	-	-	-